Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant in Early, Recurrent Prostate Cancer
NCT00217464Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jun 2004
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in prostate cancer (PCa), sponsored by Roswell Park Comprehensive Cancer Center. Started Jun 2004; status: terminated.
02
Drugs
fulvestrant
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00217464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217464.